Pamela J Paley

Summary

Publications

  1. doi request reprint Surgical outcomes in gynecologic oncology in the era of robotics: analysis of first 1000 cases
    Pamela J Paley
    Pacific Gynecology Specialists Inc, Swedish Medical Center, Seattle, WA 98104, USA
    Am J Obstet Gynecol 204:551.e1-9. 2011
  2. doi request reprint Robotic surgery in gynecologic oncology: program initiation and outcomes after the first year with comparison with laparotomy for endometrial cancer staging
    Dan S Veljovich
    Pacific Gynecology Specialists, Inc, Swedish Medical Center, Seattle WA 98104, USA
    Am J Obstet Gynecol 198:679.e1-9; discussion 679.e9-10. 2008
  3. ncbi request reprint Clear cell adenocarcinoma of the vagina in a patient with vaginal endometriosis
    Chirag Shah
    Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, University of Washington Medical Center, Box 356460, Seattle, WA 98195 6460, USA
    Gynecol Oncol 103:1130-2. 2006
  4. doi request reprint Combined weekly topotecan and biweekly bevacizumab in women with platinum-resistant ovarian, peritoneal, or fallopian tube cancer: results of a phase 2 study
    Kathryn F McGonigle
    Women s Cancer Care of Seattle, Seattle, Washington 98133, USA
    Cancer 117:3731-40. 2011
  5. ncbi request reprint Glassy cell carcinoma of the cervix revisited
    Heidi J Gray
    Department of Obstetrics and Gynecology, University of Washington School of Medicine, Seattle, WA 98195, USA
    Gynecol Oncol 85:274-7. 2002
  6. ncbi request reprint Predictors of occult neoplasia in women undergoing risk-reducing salpingo-oophorectomy
    Julie D Lamb
    Department of Obstetrics and Gynecology, University of Washington, Seattle, WA 98195 6460, USA
    Am J Obstet Gynecol 194:1702-9. 2006

Detail Information

Publications6

  1. doi request reprint Surgical outcomes in gynecologic oncology in the era of robotics: analysis of first 1000 cases
    Pamela J Paley
    Pacific Gynecology Specialists Inc, Swedish Medical Center, Seattle, WA 98104, USA
    Am J Obstet Gynecol 204:551.e1-9. 2011
    ..We sought to examine outcomes in an expanding robotic surgery (RS) program...
  2. doi request reprint Robotic surgery in gynecologic oncology: program initiation and outcomes after the first year with comparison with laparotomy for endometrial cancer staging
    Dan S Veljovich
    Pacific Gynecology Specialists, Inc, Swedish Medical Center, Seattle WA 98104, USA
    Am J Obstet Gynecol 198:679.e1-9; discussion 679.e9-10. 2008
    ..The objective of the study was to evaluate outcomes during the first year of a robotic surgery program in gynecologic oncology...
  3. ncbi request reprint Clear cell adenocarcinoma of the vagina in a patient with vaginal endometriosis
    Chirag Shah
    Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, University of Washington Medical Center, Box 356460, Seattle, WA 98195 6460, USA
    Gynecol Oncol 103:1130-2. 2006
    ..Malignant transformation of endometriosis is an infrequent complication of endometriosis. Extragonadal disease is uncommon...
  4. doi request reprint Combined weekly topotecan and biweekly bevacizumab in women with platinum-resistant ovarian, peritoneal, or fallopian tube cancer: results of a phase 2 study
    Kathryn F McGonigle
    Women s Cancer Care of Seattle, Seattle, Washington 98133, USA
    Cancer 117:3731-40. 2011
    ..A phase 2 trial was conducted to determine the toxicity and efficacy of combined weekly topotecan and biweekly bevacizumab in patients with primary or secondary platinum-resistant ovarian, peritoneal, or fallopian tube cancer (OC)...
  5. ncbi request reprint Glassy cell carcinoma of the cervix revisited
    Heidi J Gray
    Department of Obstetrics and Gynecology, University of Washington School of Medicine, Seattle, WA 98195, USA
    Gynecol Oncol 85:274-7. 2002
    ..An earlier series from our institution supported a grim prognostic outlook, demonstrating a survival rate of only 55% in women with stage I disease. We present a comparison of a contemporary series of patients with GCC...
  6. ncbi request reprint Predictors of occult neoplasia in women undergoing risk-reducing salpingo-oophorectomy
    Julie D Lamb
    Department of Obstetrics and Gynecology, University of Washington, Seattle, WA 98195 6460, USA
    Am J Obstet Gynecol 194:1702-9. 2006
    ..We hypothesized that older age and having a BRCA1 mutation would be predictors for tubal or ovarian neoplasia and that a careful surgical and pathologic protocol would lead to a low rate of subsequent primary peritoneal cancer...